DK537785A - FLAVOLIGNAN DERIVATIVES AND THEIR PREPARATION AND USE - Google Patents

FLAVOLIGNAN DERIVATIVES AND THEIR PREPARATION AND USE Download PDF

Info

Publication number
DK537785A
DK537785A DK537785A DK537785A DK537785A DK 537785 A DK537785 A DK 537785A DK 537785 A DK537785 A DK 537785A DK 537785 A DK537785 A DK 537785A DK 537785 A DK537785 A DK 537785A
Authority
DK
Denmark
Prior art keywords
flavolignan
derivatives
preparation
flavolignan derivatives
Prior art date
Application number
DK537785A
Other languages
Danish (da)
Other versions
DK164865B (en
DK164865C (en
DK537785D0 (en
Inventor
R Braatz
K Goerler
G Halbach
H Soicke
K Schmidt
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of DK537785D0 publication Critical patent/DK537785D0/en
Publication of DK537785A publication Critical patent/DK537785A/en
Publication of DK164865B publication Critical patent/DK164865B/en
Application granted granted Critical
Publication of DK164865C publication Critical patent/DK164865C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
DK537785A 1984-11-22 1985-11-21 SILIBINE INGREDIATES, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SILIBIN INGREDIENTS DK164865C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (en) 1984-11-22 1984-11-22 FLAVOLIGNANE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3442639 1984-11-22

Publications (4)

Publication Number Publication Date
DK537785D0 DK537785D0 (en) 1985-11-21
DK537785A true DK537785A (en) 1986-05-23
DK164865B DK164865B (en) 1992-08-31
DK164865C DK164865C (en) 1993-01-18

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
DK537785A DK164865C (en) 1984-11-22 1985-11-21 SILIBINE INGREDIATES, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SILIBIN INGREDIENTS

Country Status (29)

Country Link
JP (1) JPS61143377A (en)
KR (1) KR870001020B1 (en)
AR (1) AR240931A1 (en)
AT (1) AT393268B (en)
BE (1) BE903693A (en)
CA (1) CA1337124C (en)
CH (1) CH659473A5 (en)
CS (1) CS273610B2 (en)
DD (1) DD259191A1 (en)
DE (1) DE3442639A1 (en)
DK (1) DK164865C (en)
EG (1) EG19424A (en)
ES (1) ES8609311A1 (en)
FI (1) FI84064C (en)
FR (1) FR2573427B1 (en)
GB (1) GB2167414B (en)
HU (1) HU195503B (en)
IE (1) IE58791B1 (en)
IT (1) IT1190426B (en)
LU (1) LU86163A1 (en)
MX (1) MX168415B (en)
NL (1) NL192387C (en)
NO (1) NO160205C (en)
PL (1) PL146890B1 (en)
PT (1) PT81532B (en)
SE (1) SE465676B (en)
SU (1) SU1436875A3 (en)
YU (1) YU43689B (en)
ZA (1) ZA858951B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
NZ560633A (en) * 2005-03-11 2011-08-26 Neuprotect Pty Ltd Flavonoid compounds and uses thereof
RU2482844C2 (en) * 2007-11-15 2013-05-27 Мадаус Гмбх Silibilin component for treating hepatitis
US20110182858A1 (en) 2007-11-15 2011-07-28 Madaus Gmbh Silibinin component for the treatment of hepatitis
EP2430017B1 (en) 2009-05-14 2016-06-29 Madaus GmbH A method for preparing AMORPHOUS SILIBININ
PL2849736T3 (en) 2012-07-05 2019-06-28 Nutramax Laboratories, Inc. Compositions comprising the sulforaphane precursor glucoraphanin, a glucosidase, ascorbic acid and milk thistle extract or powder
CN103113359B (en) * 2013-02-22 2016-01-06 西安安健药业有限公司 Silybin bis-bias succinate and pharmaceutical salts thereof
CN103193768B (en) * 2013-02-22 2016-03-30 西安安健药业有限公司 The silybin bis-bias succinate isomer for the treatment of hepatopathy
CN103172622B (en) * 2013-02-22 2015-11-04 西安安健药业有限公司 The active isomer of silybin bis-bias succinate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (en) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybin esters with hepotoprotactant acti- - vity

Also Published As

Publication number Publication date
BE903693A (en) 1986-05-22
LU86163A1 (en) 1986-03-24
NO854655L (en) 1986-05-23
MX168415B (en) 1993-05-24
NO160205B (en) 1988-12-12
DK164865B (en) 1992-08-31
JPS61143377A (en) 1986-07-01
FI84064C (en) 1991-10-10
DD259191A1 (en) 1988-08-17
DE3442639C2 (en) 1989-08-10
JPH0432073B2 (en) 1992-05-28
FI854535A0 (en) 1985-11-18
ATA337185A (en) 1991-02-15
DE3442639A1 (en) 1986-05-22
SE8505487D0 (en) 1985-11-20
CA1337124C (en) 1995-09-26
EG19424A (en) 1995-02-28
FR2573427B1 (en) 1989-03-10
NL192387C (en) 1997-07-04
GB2167414B (en) 1989-01-11
YU178685A (en) 1988-02-29
SE8505487L (en) 1986-05-23
YU43689B (en) 1989-10-31
DK164865C (en) 1993-01-18
PL256374A1 (en) 1986-12-02
FI84064B (en) 1991-06-28
ES549116A0 (en) 1986-09-01
CH659473A5 (en) 1987-01-30
NL192387B (en) 1997-03-03
AR240931A1 (en) 1991-03-27
NL8503171A (en) 1986-06-16
SU1436875A3 (en) 1988-11-07
KR860004056A (en) 1986-06-16
PL146890B1 (en) 1989-03-31
SE465676B (en) 1991-10-14
IT1190426B (en) 1988-02-16
KR870001020B1 (en) 1987-05-23
AR240931A2 (en) 1991-03-27
IE58791B1 (en) 1993-11-17
HUT40114A (en) 1986-11-28
PT81532A (en) 1985-12-01
IT8522932A0 (en) 1985-11-21
ZA858951B (en) 1986-08-27
NO160205C (en) 1989-03-22
PT81532B (en) 1987-11-11
DK537785D0 (en) 1985-11-21
AT393268B (en) 1991-09-25
GB8528226D0 (en) 1985-12-18
CS273610B2 (en) 1991-03-12
HU195503B (en) 1988-05-30
IE852808L (en) 1986-05-22
ES8609311A1 (en) 1986-09-01
FR2573427A1 (en) 1986-05-23
FI854535A7 (en) 1986-05-23
GB2167414A (en) 1986-05-29
CS837885A2 (en) 1990-08-14

Similar Documents

Publication Publication Date Title
DK559985A (en) 13BETA-MILBEMYCINE DERIVATIVES AND THEIR PREPARATION AND USE
DK289886A (en) SUBSTITUTED 3-PHENYL-4-CYANOPYRROL DERIVATIVES AND THEIR PREPARATION AND USE
DK211582A (en) ARYLPHENYLETHER DERIVATIVES AND THEIR PREPARATION AND USE
DK520285A (en) 5-AMINO-4-HYDROXYVALYLE RELEASE DERIVATIVES AND THEIR PREPARATION AND USE
DK317588A (en) 2-ANILINO-PYRIMIDINE DERIVATIVES AND THEIR PREPARATION AND USE
DK578185A (en) 13BETA-MILBEMYCINE DERIVATIVES AND THEIR PREPARATION AND USE
DK29686A (en) 13BETA-ALKYL-MILBEMYCINE DERIVATIVES AND THEIR PREPARATION AND USE
DK420785A (en) 13-HALOGEN OR 13-HYDROXYMIL BEMYCINES AND THEIR PREPARATION AND USE
DK614084A (en) MILBEMYCIM DERIVATIVES AND THEIR PREPARATION AND USE
DK294684A (en) N-ALKYLERED 3-PHENYL-4-CYANOPYRROL DERIVATIVES AND THEIR PREPARATION AND USE
DK537785D0 (en) FLAVOLIGNAN DERIVATIVES AND THEIR PREPARATION AND USE
DK297082A (en) SUBSTITUTED 1-AZOLYL-2-HYDROXY ALKANDER DERIVATIVES AND THEIR PREPARATION AND USE
DK558484D0 (en) MILBEMYCINE DERIVATIVES AND THEIR PREPARATION AND USE
DK297182A (en) SUBSTITUTED 2-HYDROXY-3-AZOLYL PROPANDER DERIVATIVES AND THEIR PREPARATION AND USE
DK236585A (en) ACYLED HEXOSIDE DERIVATIVES AND THEIR PREPARATION AND USE
DK393285D0 (en) SUBSTITUTED CARBONYLPHENYLSULPHONYLGUANIDINES AND THEIR PREPARATION AND USE
DK172486A (en) HETEROCYCLYL-PENEM COMPOUNDS AND THEIR PREPARATION AND USE
DK119585D0 (en) 1,2,4-TRIAZACYCLOALCADIA DERIVATIVES AND THEIR PREPARATION AND USE
DK422685D0 (en) BENZAZOLD DERIVATIVES AND THEIR PREPARATION AND USE
DK77286A (en) 1-0-ACYLED HEXOSIDE DERIVATIVES AND THEIR PREPARATION AND USE
DK153285D0 (en) BENZODIOXOLD DERIVATIVES AND THEIR PREPARATION AND USE
DK181485A (en) 3-SUBSTITUTED THIOPYRONS AND THEIR PREPARATION AND USE
DK361185A (en) 2-AMINOALKYL-2-PENEM COMPOUNDS AND THEIR PREPARATION AND USE
DK437986D0 (en) 1-AMINO-3-PHENYL-PROPAN-2-OL-DERIVATIVES AND THEIR PREPARATION AND USE
DK117587A (en) 5-ACYLOXY-13BETA-ALKYL-MILBEMYCIN DERIVATIVES AND THEIR PREPARATION AND USE

Legal Events

Date Code Title Description
PBP Patent lapsed